关注
Gang Luo
Gang Luo
Director of ADME CRL-MWN
在 crl.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes
G Luo, M Cunningham, S Kim, T Burn, J Lin, M Sinz, G Hamilton, C Rizzo, ...
Drug Metabolism and Disposition 30 (7), 795-804, 2002
5592002
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
D Zhang, G Luo, X Ding, C Lu
Acta Pharmaceutica Sinica B 2 (6), 549-561, 2012
3742012
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development
G Luo, T Guenthner, LS Gan, WG Humphreys
Current drug metabolism 5 (6), 483-505, 2004
1982004
Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid
G Luo, DC Zeldin, JA Blaisdell, E Hodgson, JA Goldstein
Archives of biochemistry and biophysics 357 (1), 45-57, 1998
1431998
Investigation of the role of the 2′, 3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs
TM Guenthner, G Luo
Toxicology 160 (1-3), 47-58, 2001
942001
Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase.
F Andreola, GP Hayhurst, G Luo, SS Ferguson, FJ Gonzalez, JA Goldstein, ...
Journal of Biological Chemistry 279 (5), 3434-3438, 2004
852004
Molecular characterization of the murine HIF-1α locus
G Luo, YZ Gu, S Jain, WK Chan, KM Carr, JB Hogenesch, CA Bradfield
Gene expression 6 (5), 287, 1997
811997
Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio-and stereoselective products
CC Tsao, SJ Coulter, A Chien, G Luo, NP Clayton, R Maronpot, ...
Journal of Pharmacology and Experimental Therapeutics 299 (1), 39-47, 2001
652001
Hydrolysis of the 2', 3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
G Luo, MK Qato, TM Guenthner
Drug metabolism and disposition 20 (3), 440-445, 1992
611992
Covalent binding to DNA in vitro of 2', 3'-oxides derived from allylbenzene analogs.
G Luo, TM Guenthner
Drug metabolism and disposition 24 (9), 1020-1027, 1996
581996
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent
J Scicinski, B Oronsky, M Taylor, G Luo, T Musick, J Marini, CM Adams, ...
Drug Metabolism and Disposition 40 (9), 1810-1816, 2012
572012
Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative
G Luo, J Lin, WD Fiske, R Dai, TJ Yang, S Kim, M Sinz, E LeCluyse, ...
Drug metabolism and disposition 31 (9), 1170-1175, 2003
542003
Metabolism of allylbenzene 2', 3'-oxide and estragole 2', 3'-oxide in the isolated perfused rat liver.
G Luo, TM Guenthner
Journal of Pharmacology and Experimental Therapeutics 272 (2), 588-596, 1995
401995
In silico prediction of biliary excretion of drugs in rats based on physicochemical properties
G Luo, S Johnson, MM Hsueh, J Zheng, H Cai, B Xin, S Chong, K He, ...
Drug metabolism and disposition 38 (3), 422-430, 2010
372010
Development of an in situ toxicity assay system using recombinant baculoviruses
DF Grant, JF Greene, F Pinot, B Borhan, MF Moghaddam, BD Hammock, ...
Biochemical pharmacology 51 (4), 503-515, 1996
351996
Design and synthesis of phenylpyrrolidine phenylglycinamides as highly potent and selective TF-FVIIa inhibitors
X Zhang, W Jiang, S Jacutin-Porte, PW Glunz, Y Zou, X Cheng, ...
ACS Medicinal Chemistry Letters 5 (2), 188-192, 2014
232014
The role of P-glycoprotein in drug disposition: significance to drug development
MD Troutman, G Luo, LS Gan, DR Thakker
Drug–Drug Interactions, 295-357, 2002
20*2002
Detoxication of the 2', 3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
G Luo, TM Guenthner
Drug metabolism and disposition 22 (5), 731-737, 1994
191994
Analysis of CYP mRNA expression by branched DNA technology
M Czerwinski, P Opdam, A Madan, K Carroll, DR Mudra, LL Gan, G Luo, ...
Academic Press 357, 170-179, 2002
172002
Interaction of ritonavir on tissue distribution of a [14C] L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body …
EG Solon, SK Balani, G Luo, TJ Yang, PJ Haines, L Wang, T Demond, ...
Drug metabolism and disposition 30 (11), 1164-1169, 2002
142002
系统目前无法执行此操作,请稍后再试。
文章 1–20